Skip to content
Catalyst

PapersPMID:21544882

Effect of Salvia miltiorrhiza hydrophilic extract on antioxidant enzymes in diabetic patients with chronic heart disease: a randomized controlled trial.

Phytotherapy research2012The record ↗

findings
3
compound
1
endpoints
3
PMID:21544882
  1. Finding, very limited evidencelowersMalondialdehyde (circulating)
  2. Finding, very limited evidenceraisesSuperoxide dismutase activity
  3. Finding, very limited evidenceraisesSerum paraoxonase-1 (PON1) activity
Study, every finding
RCT
Dose studied, every finding
dose and route of administration not stated in the abstract, given on top of hypoglycemic therapy
  • “Overall, the malondialdehyde (MDA) level at day 30 in the treatment group was significantly lower than in the placebo group.”
    Duration
    4 weeks
    Population
    Diabetic patients with chronic heart disease; hypoglycemic therapy given to both arms, hydrophilic extract added in the treatment arm; day 30 timepoint only
  • “At day 60, the serum glutathione (GSH) level, superoxide dismutase (SOD), Paraoxonase (PONase) and glutathione reductase (GSSG-R) activities increased markedly in the treatment group compared with the placebo group.”
    • Duration
      2 months
      Population
      Diabetic patients with chronic heart disease; hypoglycemic therapy given to both arms, hydrophilic extract added in the treatment arm; day 60 timepoint
    • Duration
      2 months
      Population
      Diabetic patients with chronic heart disease; hypoglycemic therapy given to both arms, hydrophilic extract added in the treatment arm; day 60 timepoint

Study record

Design
randomised controlled trial
Species
human
Population
Diabetic patients with chronic heart disease (CHD); Salvia miltiorrhiza hydrophilic extract (SMHE) given on top of hypoglycemic therapy
Participants
62
Comparator
placebo
Duration
not reported
Endpoints measured
7